Agenus AGEN
NASDAQ AGEN
$6.51 +0.11 (+1.72%)
At close: Oct 22, 2026 · 4:00 PM EDT

Agenus (AGEN) Equity Income (2026)

Updated

Agenus (AGEN) reported Equity Income of $2.53 million for Q2 2026.

Analysis

Agenus (AGEN) Equity Income (2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Agenus' Equity Income came in at $1.18 million; for FY2025, it was -$26.35 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -10.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Agenus 277.43 Mn 140.37 Mn 34.52 Mn 2.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.53 Mn
Mar 31, 2026 -1.35 Mn
API Access

Agenus Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=AGEN&period=max&api_key=YOUR_API_KEY